Glenohumeral Versus Subacromial Steroid Injections for Impingement Syndrome With Mild Shoulder Stiffness
Shoulder Impingement Syndrome, Adhesive Capsulitis of Shoulder
About this trial
This is an interventional treatment trial for Shoulder Impingement Syndrome focused on measuring Glenohumeral injection, Subacromial injection, Ultrasound-guided injection, Steroid injection
Eligibility Criteria
Inclusion Criteria: Diagnosed with shoulder impingement syndrome with mild stiffness. Impingement syndrome diagnosed based Positive Hawkin's sign and Rotator cuff with intact continuity but tendinosis in MRI or US Possible subacromial enthesophyte Mild stiffness was defined as a degree of stiffness that permits activities of daily activity but still often causes endpoint ROM pain Meeting two or more of the following ROM both active & passive Abduction between 110˚ and 150˚ Forward elevation between 120˚ and 140˚ External rotation at the side between 30˚ and 50˚ Internal rotation at 90˚ of abduction between 30˚ and 50˚. Exclusion Criteria: Refused to undergo ultrasound-guided injection Diagnosed with a rotator cuff tear, calcific tendinosis, or biceps pathology History of operation, fracture, or nerve injury of the shoulder Received treatment apart from the protocol during the study
Sites / Locations
- Chuncheon Sacred Heart Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Glenohumeral injection
Subacromial injection
Ultrasound-guided posterior approach of glenohumeral space injection for impingement syndrome with mild stiffness of the shoulder. The injection mixture was: 1 mL triamcinolone, 4 mL lidocaine, 7 mL normal saline.
Ultrasound-guided anterolateral approach of subacromial space injection for impingement syndrome with mild stiffness of the shoulder. The injection mixture was: 1 mL triamcinolone, 4 mL lidocaine, 7 mL normal saline.